Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●International League of Dermatological Societies (ILDS) and European Dermatology Forum (EDF): Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis – Short version (2015)

●International Society for Photodynamic Therapy in Dermatology (I-PDT): Daylight photodynamic therapy for actinic keratosis – An international consensus (2012)

United States

●American Academy of Dermatology (AAD): Guidelines for care of the management of actinic keratosis (2021)

●Expert consensus on cosmetic outcomes after treatment of actinic keratosis (2017)

Europe

●Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis – A European consensus (2015)

●European guidelines for topical photodynamic therapy part 1 – Treatment delivery and current indications: Actinic keratoses, Bowen's disease, basal cell carcinoma (2013)

United Kingdom

●British Association of Dermatologists (BAD): Guidelines for the care of patients with actinic keratosis (2017)

Australia-New Zealand

●Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia (2016)